Long-term renal and cardiovascular risk after preeclampsia: Towards screening and prevention

Clinical Science

Volumn 130, Issue 4, 2016, Pages 239-246

  Paauw, Nina D ^a   Luijken, Kim ^a   Franx, Arie ^a   Verhaar, Marianne C ^b   Titia Lely, A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Guidelines; Postpartum cardiovascular risk; Postpartum renal risk; Preeclampsia; Prevention; Screening

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; END STAGE RENAL DISEASE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FUNCTION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA; SCREENING; CARDIOVASCULAR DISEASES; FEMALE; INCIDENCE; KIDNEY FAILURE, CHRONIC; MASS SCREENING; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRE-ECLAMPSIA; PREDICTIVE VALUE; PREGNANCY; PREVENTIVE HEALTH SERVICE; PROCEDURES; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; STANDARDS; TIME FACTOR;

CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREVENTIVE HEALTH SERVICES; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84958093508     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20150567     Document Type: Article

References (70)

1. Brown, M.C., Best, K.E., Pearce, M.S., Waugh, J., Robson, S.C. and Bell, R. (2013) Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur. J. Epidemiol. 28, 1-19
2. Mcdonald, S.D., Han, Z., Walsh, M.W., Gerstein, H.C. and Devereaux, P.J. (2010) Kidney disease after preeclampsia: a systematic review and meta-analysis. Am. J. Kidney. Dis. 55, 1026-1039
3. Van der Graaf, A.M., Toering, T.J., Faas, M.M. and Lely, A.T. (2012) From preeclampsia to renal disease: a role of angiogenic factors and the renin-angiotensin aldosterone system? Nephrol. Dial. Transplant. 27 Suppl 3, iii51-iii57
4. Wang, I.K., Muo, C.H., Chang, Y.C., Liang, C.C., Chang, C.T., Lin, S.Y., Yen, T.H., Chuang, F.R., Chen, P.C., Huang, C.C. et al. (2013) Association between hypertensive disorders during pregnancy and end-stage renal disease: a population-based study. CMAJ 185, 207-213
5. Wu, C.C., Chen, S.H., Ho, C.H., Liang, F.W., Chu, C.C., Wang, H.Y. and Lu, Y.H. (2014) End-stage renal disease after hypertensive disorders in pregnancy. Am. J. Obstet. Gynecol. 210, 147.e1-147.e8
6. Vikse, B.E., Hallan, S., Bostad, L., Leivestad, T. and Iversen, B.M. (2010) Previous preeclampsia and risk for progression of biopsy-verified kidney disease to end-stage renal disease. Nephrol. Dial. Transplant. 25, 3289-3296
7. Mosca, L., Benjamin, E.J., Berra, K., Bezanson, J.L., Dolor, R.J., Lloyd-Jones, D.M., Newby, L.K., Piña, I.L., Roger, V.L., Shaw, L.J. et al. (2011) Effectiveness-based guidelines for the prevention of cardiovascular disease in women-update: a guideline from the American Heart Association. J. Am. Coll. Cardiol. 57, 1404-1423
8. Bushnell, C., McCullough, L.D., Awad, I.A., Chireau, M.V., Fedder, W.N., Furie, K.L., Howard, V.J., Lichtman, J.H., Lisabeth, L.D. and Piña, I.L. (2014) Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 45, 1545-1588
9. Dutch Guideline Development Group on Cardiovascular Risk Management after Reproductive Disorders (2014), Cardiovascular Risk Management after Reproductive Disorders. Available at: http://nvog-documenten.nl/uploaded/docs/richtlijn%20cardiovasculair%20risicomanagement%20na%20reproductieve%20aandoeningen%20dec%202014%20(Projectplace:11451).
10. Hernandez-Diaz, S., Toh, S. and Cnattingius, S. (2009) Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ 338, b2255
11. Say, L., Chou, D., Gemmill, A., Tunçalp, Ö., Moller, A.B., Daniels, J., Gülmezoglu, A.M., Temmerman, M. and Alkema, L. (2014) Global causes of maternal death: a WHO systematic analysis. Lancet Glob. Health 2, e323-e333
12. American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy (2013) Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet. Gynecol. 122, 1122-1131
13. Tranquilli, A.L., Dekker, G., Magee, L., Roberts, J., Sibai, B.M., Steyn, W., Zeeman, G.G. and Brown, M.A. (2014) The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens. 4, 97-104
14. Lisonkova, S. and Joseph, K.S. (2013) Incidence of preeclampsia: risk factors and outcomes associated with earlyversus late-onset disease. Am. J. Obstet. Gynecol. 209, 544.e1-544.e12
15. Redman, C.W. and Sargent, I.L. (2010) Immunology of pre-eclampsia. Am. J. Reprod. Immunol. 63, 534-543
16. Redman, C.W. and Staff, A.C. (2015) Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity. Am. J. Obstet. Gynecol. 213 4 Suppl, S9.e1-S9.e4
17. Ray, J.G., Vermeulen, M.J., Schull, M.J. and Redelmeier, D.A. (2005) Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 366, 1797-1803
18. Suzuki, H., Watanabe, Y., Arima, H., Kobayashi, K., Ohno, Y. and Kanno, Y. (2008) Short-and long-term prognosis of blood pressure and kidney disease in women with a past history of preeclampsia. Clin. Exp. Nephrol. 12, 102-109
19. Heida, K.Y., Franx, A., Van Rijn, B.B., Eijkemans, M.J., Boer, J.M., Verschuren, M.W., Oudijk, M.A., Bots, M.L. and Van Derand Schouw, Y.T. (2015) Earlier age of onset of chronic hypertension and type 2 diabetes mellitus after a hypertensive disorder of pregnancy or gestational diabetes mellitus. Hypertension 66, 1116-1122
20. Van Rijn, B.B., Nijdam, M.E., Bruinse, H.W., Roest, M., Uiterwaal, C.S., Grobbee, D.E., Bots, M.L. and Franx, A. (2013) Cardiovascular disease risk factors in women with a history of early-onset preeclampsia. Obstet. Gynecol. 121, 1040-1048
21. Magnussen, E.B., Vatten, L.J., Smith, G.D. and Romundstad, P.R. (2009) Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstet. Gynecol. 114, 961-970
22. Drost, J.T., Arpaci, G., Ottervanger, J.P., De Boer, M.J., Van Eyck, J., Van Der Schouw, Y.T. and Maas, A.H. (2012) Cardiovascular risk factors in women 10 years post early preeclampsia: the preeclampsia risk evaluation in FEMales study (PREVFEM). Eur. J. Prev. Cardiol. 19, 1138-1144
23. Mangos, G.J., Spaan, J.J., Pirabhahar, S. and Brown, M.A. (2012) Markers of cardiovascular disease risk after hypertension in pregnancy. J. Hypertens 30, 351-358
24. Mcdonald, S.D., Malinowski, A., Zhou, Q., Yusuf, S. and Devereaux, P.J. (2008) Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am. Heart. J. 156, 918-930
25. Bhattacharya, S., Prescott, G.J., Iversen, L., Campbell, D.M., Smith, W.C. and Hannaford, P.C. (2012) Hypertensive disorders of pregnancy and future health and mortality: a record linkage study. Pregnancy Hypertens 2, 1-7
26. Lykke, J.A., Langhoff-Roos, J., Lockwood, C.J., Triche, E.W. and Paidas, M.J. (2010) Mortality of mothers from cardiovascular and non-cardiovascular causes following pregnancy complications in first delivery. Paediatr. Perinat. Epidemiol. 24, 323-330
27. Nilsson, P.M., Li, X., Sundquist, J. and Sundquist, K. (2009) Maternal cardiovascular disease risk in relation to the number of offspring born small for gestational age: national, multi-generational study of 2.7 million births. Acta Paediatr. 98, 985-989
28. Mongraw-Chaffin, M.L., Cirillo, P.M. and Cohn, B.A. (2010) Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension 56, 166-171
29. Li, C.Y., Chen, H.F., Sung, F.C., Chen, C.C., Lu, T.H., Yang, C.H. and Ko, M.C. (2010) Offspring birth weight and parental cardiovascular mortality. Int. J. Epidemiol. 39, 1082-1090
30. Lykke, J.A., Paidas, M.J., Triche, E.W. and Langhoff-Roos, J.F. (2012) growth and later maternal death, cardiovascular disease and diabetes. Acta Obstet. Gynecol. Scand. 91, 503-510
31. Vikse, B.E., Irgens, L.M., Leivestad, T., Skjaerven, R. and Iversen, B.M. (2008) Preeclampsia and the risk of end-stage renal disease. N. Engl. J. Med. 359, 800-809
32. Männistö, T., Mendola, P., Vaarasmaki, M., Jarvelin, M.R., Hartikainen, A.L., Pouta, A. and Suvanto, E. (2013) Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation 127, 681-690
33. Sattar, N. and Greer, I.A. (2002) Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?. BMJ 325, 157-160
34. Callaway, L.K., Lawlor, D.A., O'Callaghan, M., Williams, G.M., Najman, J.M. and McIntyre, H.D. (2007) Diabetes mellitus in the 21 years after a pregnancy that was complicated by hypertension: findings from a prospective cohort study. Am. J. Obstet. Gynecol. 197, 492.e1-492.e7
35. Carr, D.B., Newton, K.M., Utzschneider, K.M., Tong, J., Gerchman, F., Kahn, S.E., Easterling, T.R. and Heckbert, S.R. (2009) Preeclampsia and risk of developing subsequent diabetes. Hypertens. Pregnancy. 28, 435-447
36. Engeland, A., Bjorge, T., Daltveit, A.K., Skurtveit, S., Vangen, S., Vollset, S.E. and Furu, K. (2011) Risk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230,000 women in Norway. Eur. J. Epidemiol. 26, 157-163
37. Libby, G., Murphy, D.J., Mcewan, N.F., Greene, S.A., Forsyth, J.S., Chien, P.W. and Morris, A.D. (2007) Pre-eclampsia and the later development of type 2 diabetes in mothers and their children: an intergenerational study from the Walker cohort. Diabetologia 50, 523-530
38. Lykke, J.A., Langhoff-Roos, J., Sibai, B.M., Funai, E.F., Triche, E.W. and Paidas, M.J. (2009) Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 53, 944-951
39. Romundstad, P.R., Magnussen, E.B., Smith, G.D. and Vatten, L.J. (2010) Hypertension in pregnancy and later cardiovascular risk: common antecedents? Circulation 122, 579-584
40. Vikse, B.E., Irgens, L.M., Karumanchi, S.A., Thadhani, R., Reisaeter, A.V. and Skjaerven, R. (2012) Familial factors in the association between preeclampsia and later ESRD. Clin. J. Am. Soc. Nephrol. 7, 1819-1826
41. Chambers, J.C., Fusi, L., Malik, I.S., Haskard, D.O., De Swiet, M. and Kooner, J.S. (2001) Association of maternal endothelial dysfunction with preeclampsia. JAMA 285, 1607-1612
42. Germain, A.M., Romanik, M.C., Guerra, I., Solari, S., Reyes, M.S., Johnson, R.J., Price, K., Karumanchi, S.A. and Valdés, G. (2007) Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? Hypertension 49, 90-95
43. Goulopoulou, S. and Davidge, S.T. (2015) Molecular mechanisms of maternal vascular dysfunction in preeclampsia. Trends Mol. Med. 21, 88-97
44. Gant, N.F., Chand, S., Whalley, P.J. and Macdonald, P.C. (1974) The nature of pressor responsiveness to angiotensin II in human pregnancy. Obstet. Gynecol. 43, 854
45. Langer, B., Grima, M., Coquard, C., Bader, A.M., Schlaeder, G. and Imbs, J.L. (1998) Plasma active renin, angiotensin I, and angiotensin II during pregnancy and in preeclampsia. Obstet. Gynecol. 91, 196-202
46. Hladunewich, M.A., Kingdom, J., Odutayo, A., Burns, K., Lai, V., O'Brien, T., Gandhi, S., Zimpelman, J., Kiss, A., Miller, J. et al. (2011) Postpartum assessment of the renin angiotensin system in women with previous severe, early-onset preeclampsia. J. Clin. Endocrinol. Metab. 96, 3517-3524
47. Saxena, A.R., Karumanchi, S.A., Brown, N.J., Royle, C.M., McElrath, T.F. and Seely, E.W. (2010) Increased sensitivity to angiotensin II is present postpartum in women with a history of hypertensive pregnancy. Hypertension 55, 1239-1245
48. Spaanderman, M.E., Ekhart, T.H., De Leeuw, P.W. and Peeters, L.L. (2004) Angiotensin II sensitivity in nonpregnant formerly preeclamptic women and healthy parous controls. J. Soc. Gynecol. Investig. 11, 416-422
49. Van der Graaf, A.M., Toering, T., Van der Wiel, M.K., Navis, G., Buikema, H., Lely, A.T. and Faas, M.M. (2014) Angiotensin II sensitivity after preeclampsia in human and rat. SGI Abstract S-203
50. Martillotti, G., Ditisheim, A., Burnier, M., Wagner, G., Boulvain, M., Irion, O. and Pechère-Bertschi, A. (2013) Increased salt sensitivity of ambulatory blood pressure in women with a history of severe preeclampsia. Hypertension 62, 802-808
51. Wolf, M., Hubel, C.A., Lam, C., Sampson, M., Ecker, J.L., Ness, R.B., Rajakumar, A., Daftary, A., Shakir, A.S., Seely, E.W. et al. (2004) Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J. Clin. Endocrinol. Metab. 89, 6239-6243
52. Hubel, C.A., Wallukat, G., Wolf, M., Herse, F., Rajakumar, A., Roberts, J.M., Markovic, N., Thadhani, R., Luft, F.C. and Dechend, R. (2007) Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension 49, 612-617
53. Kvehaugen, A.S., Dechend, R., Ramstad, H.B., Troisi, R., Fugelseth, D. and Staff, A.C. (2011) Endothelial function and circulating biomarkers are disturbed in women and children after preeclampsia. Hypertension 58, 63-69
54. Ostlund, E., Al-Nashi, M., Hamad, R.R., Larsson, A., Eriksson, M., Bremme, K. and Kahan, T. (2013) Normalized endothelial function but sustained cardiovascular risk profile 11 years following a pregnancy complicated by preeclampsia. Hypertens. Res. 36, 1081-1087
55. Courtar, D.A., Spaanderman, M.E., Aardenburg, R., Janssen, B.J. and Peeters, L.L. (2006) Low plasma volume coincides with sympathetic hyperactivity and reduced baroreflex sensitivity in formerly preeclamptic patients. J. Soc. Gynecol. Investig. 13, 48-52
56. Hladunewich, M., Karumanchi, S.A. and Lafayette, R. (2007) Pathophysiology of the clinical manifestations of preeclampsia. Clin. J. Am. Soc. Nephrol. 2, 543-549
57. Lafayette, R.A., Druzin, M., Sibley, R., Derby, G., Malik, T., Huie, P., Polhemus, C., Deen, W.M. and Myers, B.D. (1998) Nature of glomerular dysfunction in pre-eclampsia. Kidney Int. 54, 1240-1249
58. Arnlov, J., Evans, J.C., Meigs, J.B., Wang, T.J., Fox, C.S., Levy, D., Benjamin, E.J., D'Agostino, R.B. and Vasan, R.S. (2005) Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 112, 969-975
59. Sandvik, M.K., Hallan, S., Svarstad, E. and Vikse, B.E. (2013) Preeclampsia and prevalence of microalbuminuria 10 years later. Clin. J. Am. Soc. Nephrol. 8, 1126-1134
60. Berks, D., Steegers, E.A., Molas, M. and Visser, W. (2009) Resolution of hypertension and proteinuria after preeclampsia. Obstet. Gynecol. 114, 1307-1314
61. Toering, T.J., Van der Graaf, A.M., Visser, F.W., Groen, H., Faas, M.M., Navis, G. and Lely, A.T. (2015) Higher filtration fraction in formerly early-onset preeclamptic women without comorbidity. Am. J. Physiol. Renal Physiol. 308, F824-F831
62. Helal, I., Fick-Brosnahan, G.M., Reed-Gitomer, B. and Schrier, R.W. (2012) Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat. Rev. Nephrol. 8, 293-300
63. Palatini, P., Mormino, P., Dorigatti, F., Santonastaso, M., Mos, L., De Toni, R., Winnicki, M., Dal Follo, M., Biasion, T., Garavelli, G. et al. (2006) Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: the HARVEST. Kidney Int. 70, 578-584
64. Spaan, J.J., Ekhart, T., Spaanderman, M.E. and Peeters, L.L. (2009) Remote hemodynamics and renal function in formerly preeclamptic women. Obstet. Gynecol. 113, 853-859
65. Van Beek, E., Ekhart, T.H., Schiffers, P.M., van Eyck, J., Peeters, L.L. and De Leeuw, P.W. (1998) Persistent abnormalities in plasma volume and renal hemodynamics in patients with a history of preeclampsia. Am. J. Obstet. Gynecol. 179 3 Pt 1, 690-696
66. Hamano, T. (2009) Women with a history of preeclampsia should be monitored for the onset and progression of chronic kidney disease. Nat. Clin. Pract. Nephrol. 5, 8-9
67. Appelman, Y., Van Rijn, B.B., Ten Haaf, M.E., Boersma, E. and Peters, S.A. (2015) Sex differences in cardiovascular risk factors and disease prevention. Atherosclerosis 241, 211-218
68. Manson, J.E., Chlebowski, R.T., Stefanick, M.L., Aragaki, A.K., Rossouw, J.E., Prentice, R.L., Anderson, G., Howard, B.V., Thomson, C.A., LaCroix, A.Z. et al. (2013) Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA 310, 1353-1368
69. Berks, D., Hoedjes, M., Raat, H., Duvekot, J.J., Steegers, E.A. and Habbema, J.D. (2013) Risk of cardiovascular disease after pre-eclampsia and the effect of lifestyle interventions: a literature-based study. BJOG 120, 924-931
70. Berks, D., Hoedjes, M., Raat, H., Duvekot, H.J. and Steegers, E.A. (2015) [68-OR]: Effects of lifestyle intervention after complicated pregnancy: results of the Pro-Active study. Pregnancy Hypertens. 5, 36-37